Comerica Bank
AVDL

Comerica Bank’s Avadel Pharmaceuticals AVDL Stock Holding History

Comerica Bank’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-626
Closed -$96 – 3805
2023
Q2 		$96 Buy
+626
New +$8.14K 0.01% 111
2016
Q1 		– Sell
-58,245
Closed -$595K – 2085
2015
Q4 		$595K Sell
58,245
-49,427
-46% -$771K 0.01% 1640
2015
Q3 		$1.76M Sell
107,672
-143,952
-57% -$3.17M 0.02% 1096
2015
Q2 		$5.33M Buy
251,624
+147,341
+141% +$2.64M 0.02% 894
2015
Q1 		$1.88M Sell
104,283
-58,465
-36% -$915K 0.02% 1128
2014
Q4 		$2.79M Buy
162,748
+97,771
+150% +$1.4M 0.01% 1283
2014
Q3 		$930K Buy
+64,977
New +$934K 0.01% 1529

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Comerica Bank's AVDL Position: Q3 2023 in Review

Comerica Bank sold out of Avadel Pharmaceuticals (AVDL) in Q3 2023, closing a stake of 626 shares — an estimated $96 sold.

Comerica Bank first reported a position in AVDL in Q3 2014 and held it in 7 quarters. The position peaked at $5.33M in Q2 2015. 99 funds tracked by Wall St. Rank hold AVDL as of Q3 2023.

  • Comerica Bank reported no remaining Avadel Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Comerica Bank sold 626 Avadel Pharmaceuticals shares in Q3 2023, an estimated $96.
  • Comerica Bank first reported a position in Avadel Pharmaceuticals in Q3 2014 and held it in 7 quarters.
  • Comerica Bank's Avadel Pharmaceuticals position peaked at $5.33M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2023.

Based on Comerica Bank's 13F filing for Q3 2023, filed 21 Nov 2023.